Skip to content
No results
  • About Us
  • Contact Us
  • Disclaimer
  • Event Venues
  • Events and Conferences
  • Home
  • Organizer Dashboard
  • Organizer Dashboard
  • Privacy Policy
  • Submit Organizer Form
  • Submit Organizer Form
  • Submit Venue Form
  • Submit Venue Form
  • Subscribe
  • Terms and Conditions
  • Venue Dashboard
  • Venue Dashboard
  • About Us
  • Contact Us
The Pharma Data

  • News
  • Press Releases
  • Research
  • Business
  • Regulatory
  • Events and Conferences
The Pharma Data
  • Press Releases

Merck’s Zilovertamab Vedotin Shows Promising Results in Phase 2 DLBCL Trial

  • The Pharma Data
  • May 31, 2025

Merck’s Zilovertamab Vedotin in Combination With R-GemOx Shows Promising Efficacy in Relapsed/Refractory DLBCL Patients: Phase 2 Results from waveLINE-003 Trial Presented at ASCO 2025 Merck, known as MSD outside the…

Read MoreMerck’s Zilovertamab Vedotin Shows Promising Results in Phase 2 DLBCL Trial
  • News

Merck’s KRAS G12C Inhibitor MK-1084 Shows Antitumor Activity in Early Trial

  • The Pharma Data
  • May 31, 2025

Merck Reports Encouraging Early Data for Investigational KRAS G12C Inhibitor MK-1084 in Phase 1 Trial for Advanced Colorectal and Lung Cancers Merck known as MSD outside the United States and…

Read MoreMerck’s KRAS G12C Inhibitor MK-1084 Shows Antitumor Activity in Early Trial
  • News

AbbVie and Chicago Cubs Join Forces in the Fight Against Cancer

  • The Pharma Data
  • May 31, 2025

AbbVie and the Chicago Cubs Launch Multi-Year “Striking Out Cancer” Campaign to Support Cancer Awareness and Research In a bold and heartfelt effort to turn America’s favorite pastime into a…

Read MoreAbbVie and Chicago Cubs Join Forces in the Fight Against Cancer
  • News

Teva Launches Acceleration Phase of Growth Strategy at 2025 Innovation Day

  • The Pharma Data
  • May 30, 2025

Teva Embarks on Acceleration Phase of “Pivot to Growth” Strategy at 2025 Innovation & Strategy Day, Signaling Renewed Focus on Biopharmaceutical Leadership and Long-Term Shareholder Value Teva Pharmaceutical Industries Ltd.one…

Read MoreTeva Launches Acceleration Phase of Growth Strategy at 2025 Innovation Day
  • News

China Accepts NDA for Naldemedine to Treat Opioid-Induced Constipation

  • The Pharma Data
  • May 30, 2025

China Accepts New Drug Application for Shionogi’s Naldemedine to Treat Opioid-Induced Constipation Shionogi & Co., Ltd., a leading Japanese pharmaceutical company headquartered in Osaka, has announced a key regulatory milestone…

Read MoreChina Accepts NDA for Naldemedine to Treat Opioid-Induced Constipation
  • News

Astellas, Evopoint Ink Exclusive Deal for CLDN18.2-Targeting ADC XNW27011

  • The Pharma Data
  • May 30, 2025

Astellas Secures Global Rights to Evopoint’s Promising CLDN18.2-Targeting Antibody-Drug Conjugate XNW27011 in Strategic Oncology Expansion In a strategic move that reinforces its commitment to precision oncology, Astellas Pharma Inc. has…

Read MoreAstellas, Evopoint Ink Exclusive Deal for CLDN18.2-Targeting ADC XNW27011
  • News

Analysts Downplay Intellia Setback, Gene Therapy Safety Still in Focus

  • The Pharma Data
  • May 30, 2025

Intellia Grapples with Safety Questions in ATTR Gene Editing Trial Amid Broader Sector Scrutiny Intellia Therapeutics’ stock took a steep dive Thursday morning, shedding approximately 26% of its value after…

Read MoreAnalysts Downplay Intellia Setback, Gene Therapy Safety Still in Focus
  • News

CVS Health Sues to Shield Arkansans from Impact of Act 624

  • The Pharma Data
  • May 30, 2025

CVS Health Files Federal Lawsuit to Halt Arkansas’ Act 624, Citing Harm to Patients, Jobs, and Healthcare Access On May 29, 2025, CVS Health® filed a federal lawsuit seeking to…

Read MoreCVS Health Sues to Shield Arkansans from Impact of Act 624
  • News

Beyfortus Gains Edge in First Real-World RSV Immunization Comparison

  • The Pharma Data
  • May 30, 2025

Beyfortus Shows Stronger Public Health Impact Than Maternal RSV Vaccine in Landmark Real-World Comparison In a pivotal step forward for infant respiratory health, new real-world data from an immunization program…

Read MoreBeyfortus Gains Edge in First Real-World RSV Immunization Comparison
  • News

Member States Back World Prematurity Day as Global Health Campaign

  • The Pharma Data
  • May 29, 2025

Member States Officially Endorse World Prematurity Day as a Global Health Campaign at the 78th World Health Assembly At the recently concluded 78th World Health Assembly (WHA), a historic and…

Read MoreMember States Back World Prematurity Day as Global Health Campaign
  • News

WHO Unveils New Framework Linking Climate Change and Tuberculosis Control

  • The Pharma Data
  • May 29, 2025

WHO Launches Comprehensive Framework Addressing the Intersection of Climate Change and Tuberculosis In a decisive move to confront two of the world’s most pressing public health challenges, the World Health…

Read MoreWHO Unveils New Framework Linking Climate Change and Tuberculosis Control
  • Press Releases

78th World Health Assembly Concludes with Historic Milestones

  • The Pharma Data
  • May 29, 2025

Global Unity, Historic Milestones: 78th World Health Assembly Concludes with Ambitious Health Agenda The Seventy-eighth World Health Assembly (WHA78), the flagship decision-making forum of the World Health Organization (WHO), drew…

Read More78th World Health Assembly Concludes with Historic Milestones
PrevNext
UK Biotech Day
Global Clinical
Global Clinical Trial Supply Forum 2026 I Frankfurt, Germany

About

The Pharma Data is an Information-Centric Website focused mainly on the Pharmaceutical Industry Online It is a B2B Platform mainly focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences. With The Pharma Data, you can get all the information that happening in the Pharmaceutical industry.

Advertise With Us: marketing@thepharmadata.com

Latest Posts

  • Ono Pharma Files Approval Application in Japan for Ripretinib in Advanced Gastrointestinal Stromal Tumor
  • Neurocrine Biosciences Unveils First Expert Consensus Guidelines for Tardive Dyskinesia in Long-Term Care Settings
  • Allergan Aesthetics Introduces Next-Generation JUVÉDERM Hyaluronic Acid Injectables at AMWC Monaco
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2026 | The Pharma Data | Marnet Technologies Pvt Ltd | All Rights Reserved.